Advances in Nanomaterials for Diagnosis and Therapy of Leukemia
Journal:
Recent Patents on Nanomedicine
Volume:
3
Page:
99-104
Author(s):
Swati S. Vyas and Vandana B. Patravale
Transporters at CNS Barrier Sites: Obstacles or Opportunities for Drug Delivery?
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
1422-1449
Author(s):
Lucy Sanchez-Covarrubias, Lauren M. Slosky, Brandon J. Thompson, Thomas P. Davis and Patrick T. Ronaldson
Nanoparticles vs Cancer: A Multifuncional Tool
Journal:
Current Topics in Medicinal Chemistry
Volume:
14
Page:
664-675
Author(s):
Celia N. Sanchez-Dominguez, Hugo L. Gallardo-Blanco, Arturo A. Rodriguez-Rodriguez, Andrea V. Vela-Gonzalez and Margarita Sanchez-Dominguez
Membrane Tyrosine Kinase Receptors Kit and FLT3 are an Important Targets for the Therapy of Acute Myeloid Leukemia
Journal:
Current Cancer Therapy Reviews
Volume:
9
Page:
181-219
Author(s):
Ugo Testa
Synthesis, Evaluation and Molecular Docking Studies of 1,3,4-oxadiazole- 2-thiol Incorporating Fatty Acid Moiety as Antitumor and Antimicrobial Agents
Journal:
Letters in Drug Design & Discovery
Volume:
11
Page:
304-315
Author(s):
Fatma Salah El-Din Mohamed, Ahmed Ismail Hashem, Randa Helmy Swellem and Galal Abd El-Moaen Mohamed Nawwar
Peeking into the Black Box: How Cytokine Antibody Arrays Shed Light on Molecular Mechanisms of Breast Cancer Development and its Treatment
Journal:
Current Proteomics
Volume:
10
Page:
269-277
Author(s):
Ying Lin, Shuhong Luo, Nan Shao, Shenming Wang, Chaohui Duan, Brett Burkholder, Yun Xi and Ruo-Pan Huang
Editorial (microRNA Aberrations and Their Role in Supporting Hematologic Malignancies)
Journal:
MicroRNA
Volume:
2
Page:
157-157
Author(s):
Aldo M. Roccaro and Irene M. Ghobrial
MDM2-p53 Interaction in Paediatric Solid Tumours: Preclinical Rationale, Biomarkers and Resistance
Journal:
Current Drug Targets
Volume:
15
Page:
114-123
Author(s):
Giuseppe Barone, Deborah A. Tweddle, Jason M. Shohet, Louis Chesler, Lucas Moreno, Andrew DJ Pearson and Tom Van Maerken
Therapeutic Targeting of Cancers with Loss of PTEN Function
Journal:
Current Drug Targets
Volume:
15
Page:
65-79
Author(s):
Lloye M. Dillon and Todd W. Miller
The mTOR Signaling Pathway is an Emerging Therapeutic Target in Multiple Myeloma
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
125-135
Author(s):
Jie Li, Jingyu Zhu, Biyin Cao and Xinliang Mao